EUVIMEDOpdag EUVIMED
Crossref

Characterization and Therapeutic Potential of a Novel Lytic Phage‐Derived Endolysin PA16cLys Against Uropathogenic Pseudomonas aeruginosa Biofilms

Shilin Zhang, Han Niu, Yaru Hong, Ruibing Yang, Zahid Shahbaz, Jiansong You, Zhizhong Quan, Jianguang Li, Xiaoyu Li iD, Yongping Xu, Lili Wang iD

Biotechnology and Bioengineering · 2026-07-05

DOI: 10.1002/bit.70301 ↗

At a glance

Journal article in Biotechnology and Bioengineering, published online on 2026-07-05. Written by Shilin Zhang and 10 co-authors. Institution: MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, Liaoning, China. Major MEDLINE topics: Biofilms, Pseudomonas aeruginosa, Endopeptidases, Anti-Bacterial Agents. Cited 2 times so far (Crossref); 38 references. Funded by: Basic Scientific Research Project of the Education Department of Liaoning Province, Natural Science Foundation of Liaoning Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Pseudomonas aeruginosa ( P. aeruginosa ) is a leading cause of urinary tract infections (UTIs). The escalating misuse of antibiotics has led to the emergence of multidrug‐resistant strains, necessitating novel therapeutic approaches. Bacteriophages and their encoded lytic enzymes offer unique advantages for antimicrobial therapy and show promising potential for future applications. This study focuses on the characterization of uropathogenic P. aeruginosa phages and their lytic enzymes, investigating their biological properties and potential therapeutic applications. We isolated a novel lytic bacteriophage, vB_PaeS_PA16c (PPA16c), which demonstrated favorable biological characteristics, including a 34% biofilm eradication capacity within 6 h. The phage‐encoded endolysin PA16cLys exhibited superior antibacterial efficacy compared to the phage itself. Notably, it achieved significant biofilm reduction (~63%) after 1 h treatment without requiring outer membrane permeabilizers. This endolysin exhibited enhanced antibacterial efficacy in eradicating mature P. aeruginosa biofilms. Regarding host range, PA16cLys displayed broader lytic activity. Both the phage and endolysin demonstrated cross‐order lytic activity against other pathogenic bacteria. Crucially, PA16cLys maintained potent inhibitory activity against phage‐resistant mutants. These findings provide a theoretical foundation for utilizing phages and lytic enzymes against uropathogenic P. aeruginosa and establish a research basis for developing novel antimicrobial therapy.

Subjects

MeSH terms (MEDLINE)

BiofilmsPseudomonas aeruginosaEndopeptidasesAnti-Bacterial AgentsPseudomonas PhagesUrinary Tract Infections

Author keywords

Pseudomonas aeruginosabacteriophageendolysinurinary tract infection

Substances

EndopeptidasesendolysinAnti-Bacterial Agents

Authors and institutions

  • MOE Key Laboratory of Bio-Intelligent Manufacturing, School of Bioengineering, Dalian University of Technology, Dalian, Liaoning, China.
  • R&D Center, Aim Honesty Biopharmaceutical Co. Ltd., Dalian, Liaoning, China.
  • Jimo District Market Supervision and Administration Bureau, Qingdao, Shandong, China.
  • Liaoning U&ME Future Technology Co. Ltd., Shenyang-Fushun Reform and Innovation Demonstration District, Liaoning, China.
  • Department of Animal Husbandry and Veterinary Medicine, Liaoning Agricultural Vocational and Technical College, Yingkou, Liaoning, China.

ORCID profiles: Xiaoyu Li, Lili Wang

Funding

  • Basic Scientific Research Project of the Education Department of Liaoning Province
  • Natural Science Foundation of Liaoning Province

Cite

APA

Zhang, S., Niu, H., Hong, Y., Yang, R., Shahbaz, Z., You, J., Quan, Z., Li, J., Li, X., Xu, Y., & Wang, L. (2026). Characterization and Therapeutic Potential of a Novel Lytic Phage‐Derived Endolysin PA16cLys Against Uropathogenic Pseudomonas aeruginosa Biofilms. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70301

Vancouver

Zhang S, Niu H, Hong Y, Yang R, Shahbaz Z, You J, et al. Characterization and Therapeutic Potential of a Novel Lytic Phage‐Derived Endolysin PA16cLys Against Uropathogenic Pseudomonas aeruginosa Biofilms. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70301

BibTeX
@article{Zhang2026,
  author = {Zhang, Shilin and Niu, Han and Hong, Yaru and Yang, Ruibing and Shahbaz, Zahid and You, Jiansong and Quan, Zhizhong and Li, Jianguang and Li, Xiaoyu and Xu, Yongping and Wang, Lili},
  title = {Characterization and Therapeutic Potential of a Novel Lytic Phage‐Derived Endolysin PA16cLys Against Uropathogenic Pseudomonas aeruginosa Biofilms},
  journal = {Biotechnology and Bioengineering},
  year = {2026},
  doi = {10.1002/bit.70301}
}
Start for free →